2m 2m 2m 2m 2m 2m 2m
CORB PHRM HLDGS (CRBP)
NASDAQ
$8.33-$0.13 (-1.52%)
Price as of Jun 23, 2026 7:57 PM EDT- $154.0MMarket Cap
- 6.28%1-Year Change
- BiotechnologyIndustry
CORB PHRM HLDGS (CRBP)
$8.33-$0.13 (-1.52%)
CRBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.46 | ||
Change | +$0.15 (+1.81%) | ||
Open | $8.17 | ||
High | $8.68 | ||
Low | $8.05 | ||
Previous Close | $8.31 | ||
Volume | 272,920 | ||
30-Day Average Volume | 730,651 | ||
1-Week Change | 7.36% | ||
1-Month Change | -25.46% | ||
1-Year Change | 6.28% | ||
3-Year Change | -3.75% | ||
5-Year Change | -85.83% | ||
Fundamentals | |||
Shares Outstanding | 18.5M | ||
Total Assets | $144.5M | ||
Market Cap | $154.0M | ||
Enterprise Value | $128.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.0M | ||
Free Cash Flow | -$25.6M | ||
EBIT | -$23.0M | ||
EBITDA | -$22.9M | ||
Net Working Capital | $125.4M | ||
EPS | -$1.23 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -5 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/14/2023 | ||
Earnings & Revenue